Novo Nordisk will lay off approximately 400 employees. These cuts affect its Bloomington manufacturing site. The layoffs represent about one-fifth of the facility's workforce. The parent company acquired the site from Catalent in December 2024. Impacted employees will receive severance and transition support.
Bloomington, Indiana
https://www.idsnews.com/article/2026/03/novo-nordisk-to-lay-off-400-bloomington-employees